R-954, a bradykinin B1 receptor antagonist, as a potential therapy in a preclinical endometriosis model.
Endometriosis is a gynecological condition characterized by the growth of endometrium-like tissues outside of the uterine cavity. Currently available drugs are efficacious in treating endometriosis-related pain, however it's not a …